Human Umbilical Cord Mesenchymal Stem Cells
- Generic Name
- Human Umbilical Cord Mesenchymal Stem Cells
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
Stem cells obtained from amniotic fluid, the umbilical cord (UC), and placenta are gaining in popularity. Stem cells from the umbilical cord offer several advantages, including: non-invasive collection procedures, more hearty and steady growth than bone-marrow derived stem cells (they can maintain a steady doubling time (DT) over up to 10 passages), higher d...
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety of IxCell hUC-MSC-O in Patients With Knee Osteoarthritis
- Conditions
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Shanghai IxCell Biotechnology Co., LTD
- Target Recruit Count
- 398
- Registration Number
- NCT06716281
- Locations
- 🇨🇳
The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Umbilical Cord-derived Mesenchymal Stem Cell Exosomes on Hair Growth in Patients With Androgenetic Alopecia
- Conditions
- Interventions
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 50
- Registration Number
- NCT06697080
- Locations
- 🇨🇳
Department of Plastic and Aesthetic Surgery, Nanfang Hospital Southern 8 Medical University, Guangzhou, Guangdong, China
Phase I Clinical Trial of UC-MSCs in the Treatment of Knee Osteoarthritis
- First Posted Date
- 2024-06-18
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Wuhan Union Hospital, China
- Target Recruit Count
- 18
- Registration Number
- NCT06463847
- Locations
- 🇨🇳
Wuhan Union Hospital, Wuhan, Hubei, China
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
- Conditions
- Interventions
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 38
- Registration Number
- NCT05705024
- Locations
- 🇺🇸
Department of Ophthalmology and Visual Sciences, Chicago, Illinois, United States
🇺🇸University of Maryland at Baltimore, Baltimore, Maryland, United States
🇺🇸Mass Eye and Ear Infirmary, Boston, Massachusetts, United States
Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)
- Conditions
- Interventions
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Beijing 302 Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT05224960
- Locations
- 🇨🇳
The First Hospital of Lanzhou University, Lanzhou, Gansu, China
🇨🇳Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
🇨🇳Hainan hospital of Chinese PLA General Hospital, Sanya, Hainan, China
Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy
- First Posted Date
- 2020-09-24
- Last Posted Date
- 2020-09-24
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 38
- Registration Number
- NCT04562025
- Locations
- 🇨🇳
Renmin Hospital of Wuhan university, Wuhan, Hubei China, China
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
- Conditions
- Interventions
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 8
- Registration Number
- NCT04466098
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- Banc de Sang i Teixits
- Target Recruit Count
- 26
- Registration Number
- NCT04390139
- Locations
- 🇪🇸
Mútua de Terrassa, Terrassa, Barcelona, Spain
🇪🇸Hospital Vall d'Hebron, Barcelona, Spain
🇪🇸Hospital ClÃnic de Barcelona, Barcelona, Spain
Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)
- Conditions
- Interventions
- First Posted Date
- 2020-04-14
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 28
- Registration Number
- NCT04345601
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy
- Conditions
- Interventions
- First Posted Date
- 2019-10-14
- Last Posted Date
- 2021-04-21
- Target Recruit Count
- 15
- Registration Number
- NCT04125329
- Locations
- 🇨🇳
Yan'an Hospital of Kunming City, Kunming, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.